Lisa Ferguson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lisa Ferguson has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Robyn M. Busch
Epilepsy Center Neurological Institute, Cleveland Clinic Cleveland Ohio USA
16 shared publications - Bruce P. Hermann
Department of Neurology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA
9 shared publications - Anny Reyes
Epilepsy Center and Neurological Institute, Cleveland Clinic
8 shared publications - Kayela Arrotta
Epilepsy Center, Neurological Institute Cleveland Clinic Cleveland Ohio USA
8 shared publications - Carrie R. McDonald
Departments of Psychiatry and Radiation Medicine and Applied Sciences University of California‐San Diego San Diego California USA
6 shared publications - Imad Najm
Epilepsy Center, Neurological Institute, Cleveland Clinic, OH
5 shared publications
Latest Publications
- Open Access
Deep whole genome sequencing of epileptogenic brain lesions
Objective: Malformations of cortical development and low‐grade epilepsy‐associated tumors often cause drug‐resistant lesional focal epilepsy (LFE) amenable to surgical treatment. Genetic testing of resected brain tissue can provide diagnostic and mechanistic information and may eventually support personalized treatment approaches. However, systematic >300× whole genome sequencing (GS) of bulk epileptogenic lesions, particularly after nondiagnostic deep exome sequencing and array‐based genotyping, has not been evaluated. Methods: Here, we performed deep GS (>300× coverage) on 33 epileptogenic brain lesions from individuals with LFE, selected for lesions with a high prior probability of a genetic finding, all of whom had negative results for candidate germline or somatic variants in previous deep exome sequencing (ES; >350× coverage) and array‐based genotyping. Results: We identified candidate somatic variants in known LFE‐associated genes in seven of 33 participants (21%). Two participants had two candidate variants each. In total, three of 33 participants (9%) had variants that could only be detected by GS: two deletions in TSC2 , two deletions in NPRL3 , and an exonic inversion in FGFR1 . Three individuals had germline polymorphisms that may represent modulators or risk factors. Exploratory mutational signature analysis revealed clocklike signatures and a correlation between mutational signatures, age at seizure onset, and histopathology, indicating an age‐related mechanism of mutation. Significance: Deep GS establishes the feasibility of genome‐wide profiling at a depth relevant to low‐variant allelic frequency mosaicism and reveals candidate variants missed by ES, particularly complex structural variants. As sequencing costs decrease, GS may complement other technologies in somatic variant detection, enabling more widespread clinical implementation of tissue sequencing in epilepsy surgery. Further studies are needed to address the remaining conceptual and technological challenges in somatic variant detection.
Open AccessDeep whole genome sequencing of epileptogenic brain lesions
Objective: Malformations of cortical development and low‐grade epilepsy‐associated tumors often cause drug‐resistant lesional focal epilepsy (LFE) amenable to surgical treatment. Genetic testing of resected brain tissue can provide diagnostic and mechanistic information and may eventually support personalized treatment approaches. However, systematic >300× whole genome sequencing (GS) of bulk epileptogenic lesions, particularly after nondiagnostic deep exome sequencing and array‐based genotyping, has not been evaluated. Methods: Here, we performed deep GS (>300× coverage) on 33 epileptogenic brain lesions from individuals with LFE, selected for lesions with a high prior probability of a genetic finding, all of whom had negative results for candidate germline or somatic variants in previous deep exome sequencing (ES; >350× coverage) and array‐based genotyping. Results: We identified candidate somatic variants in known LFE‐associated genes in seven of 33 participants (21%). Two participants had two candidate variants each. In total, three of 33 participants (9%) had variants that could only be detected by GS: two deletions in TSC2 , two deletions in NPRL3 , and an exonic inversion in FGFR1 . Three individuals had germline polymorphisms that may represent modulators or risk factors. Exploratory mutational signature analysis revealed clocklike signatures and a correlation between mutational signatures, age at seizure onset, and histopathology, indicating an age‐related mechanism of mutation. Significance: Deep GS establishes the feasibility of genome‐wide profiling at a depth relevant to low‐variant allelic frequency mosaicism and reveals candidate variants missed by ES, particularly complex structural variants. As sequencing costs decrease, GS may complement other technologies in somatic variant detection, enabling more widespread clinical implementation of tissue sequencing in epilepsy surgery. Further studies are needed to address the remaining conceptual and technological challenges in somatic variant detection.
- Open Access
Utility of the ADAS-Cog as a Cognitive Screening Tool in Older Adults with Epilepsy: A Multicenter Cohort Study
Objective: Cognitive impairment is common among older adults with epilepsy, although efficient screening tools suitable for routine use are lacking. Here we examine, for the first time, the utility of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) as a screening tool to identify cognitive impairment in older adults with epilepsy. Methods: Participants included 83 adults (ages ≥ 55) with epilepsy from the Brain, Aging, and Cognition in Epilepsy (BrACE) study and 83 age-, sex-, and education-matched cognitively healthy controls from the Alzheimer’s Disease Neuroimaging Initiative (ADNI-3). All completed the ADAS-Cog and a comprehensive neuropsychological battery to identify cognitive phenotypes (intact vs impaired). Performance on individual ADAS-Cog items and the total score was assessed, and diagnostic efficiency statistics were determined. Results: Epilepsy participants (mean age=66.4 years) performed significantly worse across the ADAS-Cog total score and 8 of the 13 individual test items compared to controls. The largest effect sizes were observed on verbal learning and memory tasks, particularly word recall ( d =0.87) and delayed word recall ( d =1.06). An ADAS-Cog total score of ≥15 yielded optimal diagnostic efficiency (67.5% accuracy, 68.8% sensitivity, 66.7% specificity) for identifying cognitive impairment. Significance: The ADAS-Cog is sensitive to detecting cognitive impairment in older adults with epilepsy and may represent a scalable screening option in this population. Additional comparative studies in older epilepsy populations are needed to determine the sensitivity of this measure to longitudinal change, cross-cultural applicability, and availability across languages. Plain language summary: Cognitive decline is common among older adults with epilepsy, although sufficient evidence supporting the use of screening tools to identify cognitive impairment in this population is lacking. The ADAS-Cog may be a useful screening option in epilepsy research and clinical care, although additional studies are needed to compare it with other cognitive screening tests and to confirm its applicability for clinical care and across cultures and healthcare settings. Key Points: □ ADAS-Cog, a tool widely used in Alzheimer’s disease research, was used to detect cognitive impairment in older adults with epilepsy versus healthy controls. □ Largest deficits were in verbal learning and delayed recall, aligning with epilepsy-related memory vulnerability. □ ADAS-Cog was compared with the gold standard, the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE). An ADAS-Cog-13 cutoff ≥15 showed optimal accuracy for IC-CoDE–defined cognitive impairment. □ ADAS-Cog performance reliably distinguished IC-CoDE-impaired from intact participants within the epilepsy cohort. □ These findings support ADAS-Cog as a cognitive screening tool in aging epilepsy populations to identify neurodegenerative vulnerability.
Open AccessUtility of the ADAS-Cog as a Cognitive Screening Tool in Older Adults with Epilepsy: A Multicenter Cohort Study
Objective: Cognitive impairment is common among older adults with epilepsy, although efficient screening tools suitable for routine use are lacking. Here we examine, for the first time, the utility of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) as a screening tool to identify cognitive impairment in older adults with epilepsy. Methods: Participants included 83 adults (ages ≥ 55) with epilepsy from the Brain, Aging, and Cognition in Epilepsy (BrACE) study and 83 age-, sex-, and education-matched cognitively healthy controls from the Alzheimer’s Disease Neuroimaging Initiative (ADNI-3). All completed the ADAS-Cog and a comprehensive neuropsychological battery to identify cognitive phenotypes (intact vs impaired). Performance on individual ADAS-Cog items and the total score was assessed, and diagnostic efficiency statistics were determined. Results: Epilepsy participants (mean age=66.4 years) performed significantly worse across the ADAS-Cog total score and 8 of the 13 individual test items compared to controls. The largest effect sizes were observed on verbal learning and memory tasks, particularly word recall ( d =0.87) and delayed word recall ( d =1.06). An ADAS-Cog total score of ≥15 yielded optimal diagnostic efficiency (67.5% accuracy, 68.8% sensitivity, 66.7% specificity) for identifying cognitive impairment. Significance: The ADAS-Cog is sensitive to detecting cognitive impairment in older adults with epilepsy and may represent a scalable screening option in this population. Additional comparative studies in older epilepsy populations are needed to determine the sensitivity of this measure to longitudinal change, cross-cultural applicability, and availability across languages. Plain language summary: Cognitive decline is common among older adults with epilepsy, although sufficient evidence supporting the use of screening tools to identify cognitive impairment in this population is lacking. The ADAS-Cog may be a useful screening option in epilepsy research and clinical care, although additional studies are needed to compare it with other cognitive screening tests and to confirm its applicability for clinical care and across cultures and healthcare settings. Key Points: □ ADAS-Cog, a tool widely used in Alzheimer’s disease research, was used to detect cognitive impairment in older adults with epilepsy versus healthy controls. □ Largest deficits were in verbal learning and delayed recall, aligning with epilepsy-related memory vulnerability. □ ADAS-Cog was compared with the gold standard, the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE). An ADAS-Cog-13 cutoff ≥15 showed optimal accuracy for IC-CoDE–defined cognitive impairment. □ ADAS-Cog performance reliably distinguished IC-CoDE-impaired from intact participants within the epilepsy cohort. □ These findings support ADAS-Cog as a cognitive screening tool in aging epilepsy populations to identify neurodegenerative vulnerability.
- Open Access
- 28 May 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 182, 111137
Comparing normative and ipsative methods of IC-CoDE phenotype classification in frontal lobe epilepsy
- 28 May 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 182, 111137
Open AccessComparing normative and ipsative methods of IC-CoDE phenotype classification in frontal lobe epilepsy
- Open Access
The International Classification of Cognitive Disorders in Epilepsy ( IC ‐ CoDE ) Portal: An open source resource for neuropsychological research in epilepsy
Objective: The International Classification of Cognitive Disorders in Epilepsy (IC‐CoDE) is a consensus‐based, empirically‐driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC‐CoDE phenotypes in group data is laborious and time‐consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC‐CoDE phenotypes to further multicenter epilepsy research. Methods: To remove this barrier, we developed the IC‐CoDE Portal ( https://ic‐code‐portal.ccf.org/ ), an interactive and user‐friendly, web‐based platform to support the scientific community in performing IC‐CoDE individual level classification through web interface or bulk classification through uploading of data files. The Portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC‐CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC‐CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi‐center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC‐CoDE Portal will springboard large‐scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
Open AccessThe International Classification of Cognitive Disorders in Epilepsy ( IC ‐ CoDE ) Portal: An open source resource for neuropsychological research in epilepsy
Objective: The International Classification of Cognitive Disorders in Epilepsy (IC‐CoDE) is a consensus‐based, empirically‐driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC‐CoDE phenotypes in group data is laborious and time‐consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC‐CoDE phenotypes to further multicenter epilepsy research. Methods: To remove this barrier, we developed the IC‐CoDE Portal ( https://ic‐code‐portal.ccf.org/ ), an interactive and user‐friendly, web‐based platform to support the scientific community in performing IC‐CoDE individual level classification through web interface or bulk classification through uploading of data files. The Portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC‐CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC‐CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi‐center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC‐CoDE Portal will springboard large‐scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
- Open Access
- 30 April 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (3) , 1003-1016
Neuroanatomical correlates of neuropsychological dysfunction in pediatric pharmacoresistant epilepsy due to focal cortical dysplasia type II
Objective: Children and adolescents with pharmacoresistant epilepsy (PRE) show marked individual cognitive and emotional variability not fully accounted for by demographic or clinical variables. This exploratory pilot study characterizes neuroanatomical abnormalities and their relationships with neuropsychological functioning in a pediatric patient cohort with PRE due to type II focal cortical dysplasia (FCD). Methods: Retrospective data were obtained from patients with histopathologically confirmed FCD II who completed presurgical evaluations including high‐resolution 3T MRI and neuropsychological assessment. Voxel‐based morphometric MRI postprocessing using the Morphometric Analysis Program (MAP18) provided age‐adjusted quantitative characterizations of within‐lesion MRI features [Junction (gray–white matter junction blurring), Extension (abnormal gyration), and Thickness (cortical thickening in the regional lesion)]. Associations between MRI feature z‐scores and cognitive domain composite scores were evaluated using Pearson correlation coefficients and multivariable linear and logistic regression models, controlling for seizure side and site. Lesion ROI volumes were also analyzed to evaluate their associations with MRI feature z‐scores and neuropsychological function. Results: We included 24 patients [mean age = 13.8; 58% male] with FCD IIa ( n = 8; 33%) or FCD IIb ( n = 16; 67%). Patients with FCD IIb had higher mean and maximum Junction z‐scores compared to those with FCD IIa (Cohen's d = 1.00 and 1.07). Mean and maximum Thickness z‐scores were negatively associated with attention ( r = −0.32; r = −0.47) and general cognitive ability (GCA; r = −0.46; r = −0.41). Mean Thickness z‐scores were also negatively associated with visuospatial skills ( r = −0.34). In regression models, higher mean and maximum Thickness were associated with poorer GCA scores (estimate (se): −14.98 (6.88), p = 0.042; −5.76 (2.41), p = 0.027, respectively), and higher maximum Thickness was associated with worse attention scores (estimate (se): −6.02 (2.60), p = 0.032). Lesion volumes were not associated with MRI feature z‐scores, cognition, self‐reported mood or anxiety. Significance: Our findings showed that lesional neuroanatomical abnormalities, particularly increased cortical thickness, were associated with poorer cognitive performance in pediatric patients with FCD II. Future research in larger, more diverse samples is needed to identify other factors contributing to neuropsychological variability in this population. Plain Language Summary: We studied 24 pediatric patients with pharmacoresistant epilepsy (PRE) and a confirmed diagnosis of focal cortical dysplasia type II (FCD II) to examine how MRI findings relate to thinking abilities. Patients with FCD IIb showed more pronounced MRI abnormalities than FCD IIa. Greater cortical thickening within the lesion was associated with difficulties in overall cognitive ability, attention, and visuospatial skills. After adjusting for seizure side and site, the relationships between cortical thickness and reduced overall cognitive ability and attention performance remained significant. Findings suggest that specific MRI features may serve as imaging markers of cognition in pediatric patients with FCD II.
- 30 April 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (3) , 1003-1016
Open AccessNeuroanatomical correlates of neuropsychological dysfunction in pediatric pharmacoresistant epilepsy due to focal cortical dysplasia type II
Objective: Children and adolescents with pharmacoresistant epilepsy (PRE) show marked individual cognitive and emotional variability not fully accounted for by demographic or clinical variables. This exploratory pilot study characterizes neuroanatomical abnormalities and their relationships with neuropsychological functioning in a pediatric patient cohort with PRE due to type II focal cortical dysplasia (FCD). Methods: Retrospective data were obtained from patients with histopathologically confirmed FCD II who completed presurgical evaluations including high‐resolution 3T MRI and neuropsychological assessment. Voxel‐based morphometric MRI postprocessing using the Morphometric Analysis Program (MAP18) provided age‐adjusted quantitative characterizations of within‐lesion MRI features [Junction (gray–white matter junction blurring), Extension (abnormal gyration), and Thickness (cortical thickening in the regional lesion)]. Associations between MRI feature z‐scores and cognitive domain composite scores were evaluated using Pearson correlation coefficients and multivariable linear and logistic regression models, controlling for seizure side and site. Lesion ROI volumes were also analyzed to evaluate their associations with MRI feature z‐scores and neuropsychological function. Results: We included 24 patients [mean age = 13.8; 58% male] with FCD IIa ( n = 8; 33%) or FCD IIb ( n = 16; 67%). Patients with FCD IIb had higher mean and maximum Junction z‐scores compared to those with FCD IIa (Cohen's d = 1.00 and 1.07). Mean and maximum Thickness z‐scores were negatively associated with attention ( r = −0.32; r = −0.47) and general cognitive ability (GCA; r = −0.46; r = −0.41). Mean Thickness z‐scores were also negatively associated with visuospatial skills ( r = −0.34). In regression models, higher mean and maximum Thickness were associated with poorer GCA scores (estimate (se): −14.98 (6.88), p = 0.042; −5.76 (2.41), p = 0.027, respectively), and higher maximum Thickness was associated with worse attention scores (estimate (se): −6.02 (2.60), p = 0.032). Lesion volumes were not associated with MRI feature z‐scores, cognition, self‐reported mood or anxiety. Significance: Our findings showed that lesional neuroanatomical abnormalities, particularly increased cortical thickness, were associated with poorer cognitive performance in pediatric patients with FCD II. Future research in larger, more diverse samples is needed to identify other factors contributing to neuropsychological variability in this population. Plain Language Summary: We studied 24 pediatric patients with pharmacoresistant epilepsy (PRE) and a confirmed diagnosis of focal cortical dysplasia type II (FCD II) to examine how MRI findings relate to thinking abilities. Patients with FCD IIb showed more pronounced MRI abnormalities than FCD IIa. Greater cortical thickening within the lesion was associated with difficulties in overall cognitive ability, attention, and visuospatial skills. After adjusting for seizure side and site, the relationships between cortical thickness and reduced overall cognitive ability and attention performance remained significant. Findings suggest that specific MRI features may serve as imaging markers of cognition in pediatric patients with FCD II.
- 16 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110938
Defining cognitive impairment in temporal lobe epilepsy with IC-CoDE phenotypes: A comparison of normative and ipsative approaches
- 16 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110938
Defining cognitive impairment in temporal lobe epilepsy with IC-CoDE phenotypes: A comparison of normative and ipsative approaches
- 11 December 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 175, 110833
Disentangling deprivation: Differential associations of the area deprivation index- 3 factors with clinical, cognitive, and mood outcomes in epilepsy
- 11 December 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 175, 110833
Disentangling deprivation: Differential associations of the area deprivation index- 3 factors with clinical, cognitive, and mood outcomes in epilepsy
- Open Access
The International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) Portal: An Open Source Resource for Neuropsychological Research in Epilepsy
Background: The International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) is a consensus-based, empirically-driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC-CoDE phenotypes in group data is laborious and time-consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC-CoDE phenotypes to further multicenter epilepsy research. Methods/Results: To remove this barrier, we developed the IC-CoDE portal ( https://ic-code-portal.ccf.org/ ), an interactive and user-friendly, web-based platform to support the scientific community in performing IC-CoDE individual level classification through web interface or bulk classification through upload of data files. The portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC-CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC-CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi-center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC-CoDE portal will springboard large-scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
Open AccessThe International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) Portal: An Open Source Resource for Neuropsychological Research in Epilepsy
Background: The International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) is a consensus-based, empirically-driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC-CoDE phenotypes in group data is laborious and time-consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC-CoDE phenotypes to further multicenter epilepsy research. Methods/Results: To remove this barrier, we developed the IC-CoDE portal ( https://ic-code-portal.ccf.org/ ), an interactive and user-friendly, web-based platform to support the scientific community in performing IC-CoDE individual level classification through web interface or bulk classification through upload of data files. The portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC-CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC-CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi-center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC-CoDE portal will springboard large-scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
- Open Access
- 29 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110607
Application of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) to youths with drug-resistant epilepsy
- 29 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 171, 110607
Open AccessApplication of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) to youths with drug-resistant epilepsy
- Open Access
- 19 February 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 164, 110279
Neuropsychological functioning in children and adolescents with pharmacoresistant epilepsy due to malformations of cortical development
- 19 February 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 164, 110279
Open AccessNeuropsychological functioning in children and adolescents with pharmacoresistant epilepsy due to malformations of cortical development